No Prescription |
 |
 | ||
|
LUPITETRA Resteclin |
|
| ||
No Prescription » Prescription Drugs 10 » LUPITETRA Resteclin Tetracycline is used to treat bacterial infections including pneumonia and other respiratory tract infections; acne; infections of skin genital and urinary systems; and the infection that causes stomach ulcers (Helicobacter pylori). It also may be used as an alternative to other medications for the treatment of Lyme disease and for the treatment and prevention of anthrax (after inhalational exposure). Tetracycline is in a class of medications called tetracycline antibiotics.It works by preventing the growth and spread of bacteria. Antibiotics will not work for colds flu or other viral infections.Tetracycline comes as a capsule and suspension (liquid) to take by mouth. It is usually taken two to four times daily. Tetracycline should be taken on an empty stomach at least 1 hour before or 2 hours after meals or snacks. Drink a full glass of water with each dose of tetracycline. Do not take tetracycline with food especially dairy products such as milk yogurt cheese and ice cream. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take tetracycline exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor. Buy LUPITETRA Resteclin and other Prescription Drugs 10 products online at Medstore. 700
About LUPITETRA Resteclin: Product Type: Prescription Drugs 10 LUPITETRA ( Resteclin Achromycin V Panmycin Sumycin Tetracap Generic Tetracycline ) LUPITETRA (Resteclin Achromycin V Panmycin Sumycin Tetracap Generic Tetracycline) Resteclin Achromycin V Panmycin Sumycin Tetracap Generic Tetracycline 250mg Caps 100 (10 x 10) Resteclin Achromycin V Panmycin Sumycin Tetracap Generic Tetracycline LUPITETRA
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
